Media Release: 12 March 2014
NICM is undertaking clinical research into the use of a standardised Chinese herbal medicine formula to treat vascular dementia. A Multicentre, Randomised, Double Blind, Placebo Controlled Trial to Evaluate the Effectiveness and Safety of Sailuotong, a Standardised Chinese Herbal Medicine Formula in Patients with Vascular Dementia and Alzheimer's Disease with Cerebrovascular Disease.
The project is being funded by Australia Shineway Technology Pty Ltd and comes after a series of preclinical and clinical investigations, which showed encouraging results.
Currently there is no cure for vascular dementia," said co-project leader Associate Professor Dennis Chang. "Dementia is a leading cause of disability in the elderly. Vascular dementia (VaD) is the second most widespread accounting for 15-20 per cent of all dementia cases in Western countries, and it is estimated it will affect more than 150,000 Australians by 2050." Read more PDF, 2841.35 KB (opens in a new window)
If you have any questions about the project, please contact Associate Professor Dennis Chang email@example.com